COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
The National Academy of Medicine has named an international committee to assess how COVID-19 vaccine development and other policies could facilitate global efforts to prepare for seasonal flu and a flu pandemic.
The Food and Drug Administration authorized the first molecular test to detect the SARS-CoV-2 virus in a nasal swab at home without a prescription. Cue Health expects by summer to daily produce more than 100,000 of the tests, authorized for use in patients age 2 and older.
The Centers for Disease Control and Prevention released interim guidelines for fully vaccinated individuals鈥 social practices. CDC said that those who are fully vaccinated 鈥 whether the two doses required by the Pfizer and Moderna vaccines, or the single Johnson & Johnson dose 鈥 may eschew鈥
Mask mandates last year were associated with declining growth in daily COVID-19 cases and deaths within 20 days, while on-premises restaurant dining was associated with rising cases after 40 days and rising death rates after 60 days, according to a study released by the Centers for Disease Control鈥
The Centers for Disease Control and Prevention will host a March 11 call for clinicians on using telehealth to augment COVID-19 vaccine planning and monitoring.
To help hospitals and health systems address maternal and neonatal health during this public crisis, the AHA has assembled resources from across the field that you may find useful as you provide safe and high-quality care to mothers and babies during this time.
The Food and Drug Administration has called on 25 firms to stop producing and issuing so-called 鈥淔DA registration certificates鈥 to mask, respirator, face shield and other medical device makers and distributors that create the impression that FDA has approved or authorized their products.
The Food and Drug Administration granted an emergency use authorization for Johnson & Johnson鈥檚 single-dose COVID-19 vaccine.
The Centers for Medicare & Medicaid Services released guidance clarifying federal requirements for health plans to cover certain items and services related to diagnostic testing for COVID-19 without cost-sharing, prior authorization or other medical management requirements.
The Food and Drug Administration鈥檚 Vaccines and Related Biological Products Advisory Committee recommended the approval of Johnson & Johnson鈥檚 COVID-19 vaccine candidate.